Our Core Business
HYPERION Life Sciences is focused on the following business segments
Pharmaceuticals
Nutraceuticals
Cosmetics/Skin Care
Medical devices
Animal health
Aesthetic Medicine
We are specialist of Emerging markets
In 2012, pharmerging markets already accounted for 50% of the top 20 worldwide pharmaceuticals markets.
Source: IMS Market Prognosis, March 2013; Marketsize ranking in USD for 2007 and 2012; For 2017 in constant USD.
Between 2013 and 2021 pharmerging markets will account for more than 2/3 of the global pharmaceutical growth.
By 2021 Asia will represent the primary source of revenue of the worldwide pharmaceutical industry and Latam will have the strongest growth.
Source: IMS Market Prognosis, March 2013; Marketsize ranking in USD for 2007 and 2012; For 2017 in constant USD.
Now the global pharmaceutical market growth is clearly driven by emerging markets
Source: IMS Market Prognosis, March 2013
Size of different Life Sciences business segments in emerging markets in 2012.
Source: IMS Health 2013, Epsicon 2013, Euromonitor 2013
* Include skin care, hair care, baby and child-specific products, bath & shower, deodorants, colour cosmetics, men's grooming, oral hygiene, fragrances, depilatories, sun care and sets/kits.
Source: IMS Health 2013, Epsicon 2013, Euromonitor 2013